Search filters

List of works by Özcan Met

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

scientific article published on 9 July 2021

Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function.

scientific article

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

scientific article

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

scientific article published on 26 September 2018

Analysis of survivin-specific T cells in breast cancer patients using human DCs engineered with survivin mRNA.

scientific article published on January 2013

Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.

scientific article published on 13 July 2016

Broadening the repertoire of melanoma-associated T-cell epitopes.

scientific article published on 18 February 2015

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

scientific article published on 30 September 2016

Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

article

Cellular based cancer vaccines: type 1 polarization of dendritic cells.

scientific article published on January 2012

Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

scientific article published on 18 April 2018

Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients

scientific article published on 11 April 2008

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study.

scientific article

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

scientific article published on 06 August 2019

Frequent adaptive immune responses against arginase-1.

scientific article published on 26 December 2017

HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

scientific article published on 17 January 2013

High frequency of T cells specific for cryptic epitopes in melanoma patients

scientific article published on July 2013

High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

scientific article published on 25 March 2010

INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels

scientific article published on 10 November 2020

Immune Monitoring Using mRNA-Transfected Dendritic Cells.

scientific article

Immunobiological Effects of Glucosamine In Vitro ⬇️

scientific article published on October 1, 2003

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.

scientific article published on 26 December 2017

In-chip fabrication of free-form 3D constructs for directed cell migration analysis.

scientific article published in December 2013

Large-Scale mRNA Transfection of Dendritic Cells by Electroporation in Continuous Flow Systems.

scientific article published in January 2016

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

scientific article published on 22 March 2016

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.

scientific article published on July 2016

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

scientific article published on 27 January 2022

Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC.

scientific article

Principles of adoptive T cell therapy in cancer

scientific article published on 05 September 2018

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

scientific article published on 12 November 2020

Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells ⬇️

scientific article published on June 1, 2013

Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor.

scientific article published on 13 May 2014

Special AT rich-binding1 protein (SATB1) in malignant T cells.

scientific article

Spontaneous presence of FOXO3-specific T cells in cancer patients.

scientific article published on 14 November 2014

Studies on mRNA Electroporation of Immature and Mature Dendritic Cells: Effects on their Immunogenic Potential

scientific article published on 10 June 2008

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

scientific article published on 30 September 2019

T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression.

scientific article published on 24 April 2018

T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road

scientific article published on 30 June 2020

T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy.

scientific article published on 4 January 2018

T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors

scientific article published on 13 February 2014

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.

scientific article

The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

scientific article published on 14 August 2020

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

scientific article

The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling

scientific article published on 01 January 2006

The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.

scientific article published in November 2017

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

scientific article published on 01 June 2020

Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells

scientific article published on 29 June 2016

Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2

scientific article published on 01 January 2016

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

scientific article published on 30 January 2015

Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

scientific article published in 2022

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

scientific article published on 02 June 2021

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

scientific article

Paulina is supported by:

About Paulina

Help